Donoghue Forlines’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.36M | Buy |
29,377
+5,049
| +21% | +$234K | 0.39% | 101 |
|
2025
Q1 | $1.48M | Sell |
24,328
-3,473
| -12% | -$212K | 0.47% | 80 |
|
2024
Q4 | $1.57M | Buy |
27,801
+10,106
| +57% | +$572K | 0.53% | 58 |
|
2024
Q3 | $916K | Buy |
17,695
+949
| +6% | +$49.1K | 0.26% | 120 |
|
2024
Q2 | $695K | Buy |
16,746
+2,262
| +16% | +$93.9K | 0.2% | 107 |
|
2024
Q1 | $785K | Buy |
14,484
+3,892
| +37% | +$211K | 0.22% | 97 |
|
2023
Q4 | $543K | Sell |
10,592
-11,474
| -52% | -$589K | 0.17% | 155 |
|
2023
Q3 | $1.28M | Buy |
22,066
+6,071
| +38% | +$352K | 0.46% | 60 |
|
2023
Q2 | $1.02M | Buy |
15,995
+3,256
| +26% | +$208K | 0.32% | 78 |
|
2023
Q1 | $883K | Sell |
12,739
-22,421
| -64% | -$1.55M | 0.32% | 90 |
|
2022
Q4 | $2.53M | Buy |
35,160
+20,143
| +134% | +$1.45M | 0.89% | 17 |
|
2022
Q3 | $1.07M | Sell |
15,017
-22,638
| -60% | -$1.61M | 0.39% | 30 |
|
2022
Q2 | $2.9M | Sell |
37,655
-7,548
| -17% | -$581K | 0.76% | 18 |
|
2022
Q1 | $3.3M | Buy |
45,203
+21,557
| +91% | +$1.57M | 0.72% | 20 |
|
2021
Q4 | $1.47M | Sell |
23,646
-17,093
| -42% | -$1.07M | 0.25% | 86 |
|
2021
Q3 | $2.41M | Sell |
40,739
-683
| -2% | -$40.4K | 0.47% | 45 |
|
2021
Q2 | $2.77M | Sell |
41,422
-340
| -0.8% | -$22.7K | 0.52% | 44 |
|
2021
Q1 | $2.64M | Buy |
41,762
+18,198
| +77% | +$1.15M | 0.51% | 40 |
|
2020
Q4 | $1.46M | Buy |
23,564
+3,467
| +17% | +$215K | 0.28% | 89 |
|
2020
Q3 | $1.21M | Buy |
+20,097
| New | +$1.21M | 0.33% | 78 |
|
2020
Q2 | – | Sell |
-13,414
| Closed | -$748K | – | 65 |
|
2020
Q1 | $748K | Sell |
13,414
-37,944
| -74% | -$2.12M | 0.17% | 29 |
|
2019
Q4 | $3.3M | Sell |
51,358
-37,345
| -42% | -$2.4M | 0.51% | 53 |
|
2019
Q3 | $4.5M | Sell |
88,703
-54,870
| -38% | -$2.78M | 0.64% | 30 |
|
2019
Q2 | $6.51M | Buy |
+143,573
| New | +$6.51M | 0.76% | 50 |
|